Gene · 3046
Papers4,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,524
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRISPR-Cas9 Targeting of Hepatitis B Virus Covalently Closed Circular DNA Generates Transcriptionally Active Episomal Variants. | mBio | 2022 | 35389262 | PubTator, text mining | PubMed |
| Antibodies as biomarkers for cancer risk: a systematic review. | Clin Exp Immunol | 2022 | 35380164 | PubTator, text mining | PubMed |
| Plasma proteome profiling combined with clinical and genetic features reveals the pathophysiological characteristics of β-thalassemia. | iScience | 2022 | 35378860 | PubTator, text mining | PubMed |
| [Factors associated with hepatitis B infection in pregnant women at health facilities in the health district of Mokolo/Far North of Cameroon]. | Pan Afr Med J | 2022 | 35371374 | PubTator, text mining | PubMed |
| Antigen presentation by MHC-E: a putative target for vaccination? | Trends Immunol | 2022 | 35370095 | PubTator, text mining | PubMed |
| Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry. | J Cell Mol Med | 2022 | 35355397 | PubTator, text mining | PubMed |
| HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B. | Viruses | 2022 | 35336990 | PubTator, text mining | PubMed |
| Imaging of Hepatitis B Virus Nucleic Acids: Current Advances and Challenges. | Viruses | 2022 | 35336964 | PubTator, text mining | PubMed |
| Ca2+/Calmodulin-Dependent Protein Kinase II Inhibits Hepatitis B Virus Replication from cccDNA via AMPK Activation and AKT/mTOR Suppression. | Microorganisms | 2022 | 35336076 | PubTator, text mining | PubMed |
| Down-regulation of the transcriptional repressor ZNF802 (JAZF1) reactivates fetal hemoglobin in β0-thalassemia/HbE. | Sci Rep | 2022 | 35322124 | PubTator, text mining | PubMed |
| Iron overload status in patients with non-transfusion-dependent thalassemia in China. | Ther Adv Hematol | 2022 | 35321211 | PubTator, text mining | PubMed |
| Innate and adaptive immune escape mechanisms of hepatitis B virus. | World J Gastroenterol | 2022 | 35317051 | PubTator, text mining | PubMed |
| The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro. | PLoS Pathog | 2022 | 35312737 | PubTator, text mining | PubMed |
| Dynamics of Serum Pregenome RNA in Chronic Hepatitis B Patients Receiving 96-Month Nucleos(t)ide Analog Therapy. | Front Med (Lausanne) | 2022 | 35295596 | PubTator, text mining | PubMed |
| Natural antibody IgG levels are associated with HBeAg-positivity and seroconversion in chronic hepatitis B patients treated with entecavir. | Sci Rep | 2022 | 35288624 | PubTator, text mining | PubMed |
| Genetic Influence on Neurodevelopment in Nonsyndromic Craniosynostosis. | Plast Reconstr Surg | 2022 | 35286293 | PubTator, text mining | PubMed |
| Moyamoya syndrome in a child with HbEβ-thalassemia. | Clin Case Rep | 2022 | 35280101 | PubTator, text mining | PubMed |
| Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues. | J Viral Hepat | 2022 | 35274400 | PubTator, text mining | PubMed |
| α0-thalassemia in affected fetuses with hemoglobin E-β0-thalassemia disease in a high-risk population in Thailand. | Am J Transl Res | 2022 | 35273733 | PubTator, text mining | PubMed |
| Prevalence, genotype distribution and mutations of hepatitis B virus and the associated risk factors among pregnant women residing in the northern shores of Persian Gulf, Iran. | PLoS One | 2022 | 35271684 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3046/papers?page=37